Pancytopenia After Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis
We present two hemodialysis patients with RA who presented with a complication of severe pancytopenia after treatment with MTX. After receiving various supportive and blood purification treatments, both patients recovered. We reviewed twenty-four pancytopenia patients on dialysis associated with methotrexate. Among these patients, high morbidity and mortality were observed, indicating that MTX should be used cautiously in the absence of alternatives in such a population. Compared with the patients who recovered, the deceased patients showed a lower level of leukocytes. Which dialysis method might be the best choice is unclear. The mode of renal replacement therapy can be chosen according to the actual situation.PMID:34562416 | DOI:10.1016/j.amjms.2021.08.008
Source: The American Journal of the Medical Sciences - Category: General Medicine Authors: Tao Pu Yu Ni Pan-Hong Li Dan Yu Qiong Yu Li-Mei Yu Source Type: research
More News: Arthritis | Dialysis | Gastroenterology | General Medicine | Hemodialysis | Methotrexate | Pancytopenia | Renal Failure | Rheumatoid Arthritis | Rheumatology